Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'TEMSAMANI J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 28 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Temsamani, J; Rousselle, C; Rees, AR; Scherrmann, JM
      Vector-mediated drug delivery to the brain

      EXPERT OPINION ON BIOLOGICAL THERAPY
    2. Mazel, M; Clair, P; Rousselle, C; Vidal, P; Scherrmann, JM; Mathieu, D; Temsamani, J
      Doxorubicin-peptide conjugates overcome multidrug resistance

      ANTI-CANCER DRUGS
    3. Rousselle, C; Smirnova, M; Clair, P; Lefauconnier, JM; Chavanieu, A; Calas, B; Scherrmann, JM; Temsamani, J
      Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: Saturation kinetics and specificity

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. Drin, G; Mazel, M; Clair, P; Mathieu, D; Kaczorek, M; Temsamani, J
      Physico-chemical requirements for cellular uptake of pAntp peptide - Role of lipid-binding affinity

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    5. Drin, G; Demene, H; Temsamani, J; Brasseur, R
      Translocation of the pAntp peptide and its amphipathic analogue AP-2AL

      BIOCHEMISTRY
    6. Rousselle, C; Clair, P; Lefauconnier, JM; Kaczorek, M; Scherrmann, JM; Temsamani, J
      New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy

      MOLECULAR PHARMACOLOGY
    7. Zhao, QY; Zhou, RZ; Temsamani, J; Zhang, ZW; Roskey, A; Agrawal, S
      Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    8. GUINOT P; TEMSAMANI J
      ANTISENSE OLIGONUCLEOTIDES - A NOVEL THER APEUTIC APPROACH

      Pathologie et biologie
    9. ZHAO QY; TEMSAMANI J; ZHOU RZ; AGRAWAL S
      PATTERN AND KINETICS OF CYTOKINE PRODUCTION FOLLOWING ADMINISTRATION OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES IN MICE

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    10. TEMSAMANI J; ROSKEY A; CHAIX C; AGRAWAL S
      IN-VIVO METABOLIC PROFILE OF A PHOSPHOROTHIOATE OLIGODEOXYRIBONUCLEOTIDE

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    11. TEMSAMANI J; GUINOT P
      ANTISENSE OLIGONUCLEOTIDES - A NEW THERAPEUTIC APPROACH

      Biotechnology and applied biochemistry
    12. TEMSAMANI J; MAYRAND SH; PEDERSON T
      THE C HNRNP PROTEINS BIND TO THE 5'-STEM-LOOP OF THE U2 SMALL NUCLEARRIBONUCLEOPROTEIN PARTICLE

      Molecular biology of the cell
    13. AGRAWAL S; IADAROLA PL; TEMSAMANI J; ZHAO QY; SHAW DR
      EFFECT OF G-RICH SEQUENCES ON THE SYNTHESIS, PURIFICATION, HYBRIDIZATION, CELL UPTAKE, AND HEMOLYTIC-ACTIVITY OF OLIGONUCLEOTIDES

      Bioorganic & medicinal chemistry letters
    14. TEMSAMANI J; PEDERSON T
      THE C-GROUP HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN PROTEINS BIND TO THE 5'-STEM-LOOP OF THE U2 SMALL NUCLEAR RIBONUCLEOPROTEIN PARTICLE

      The Journal of biological chemistry
    15. ZHAO QY; TEMSAMANI J; IADAROLA PL; AGRAWAL S
      MODULATION OF OLIGONUCLEOTIDE-INDUCED IMMUNE STIMULATION BY CYCLODEXTRIN ANALOGS

      Biochemical pharmacology
    16. ZHAO QY; TEMSAMANI J; IADAROLA PL; JIANG ZW; AGRAWAL S
      EFFECT OF DIFFERENT CHEMICALLY-MODIFIED OLIGODEOXYNUCLEOTIDES ON IMMUNE STIMULATION

      Biochemical pharmacology
    17. ZHAO QY; TEMSAMANI J; AGRAWAL S
      USE OF CYCLODEXTRIN AND ITS DERIVATIVES AS CARRIERS FOR OLIGONUCLEOTIDE DELIVERY

      Antisense research and development
    18. KANDIMALLA ER; TEMSAMANI J; AGRAWAL S
      SYNTHESIS AND PROPERTIES OF 2'-O-METHYLRIBONUCLEOTIDE METHYLPHOSPHONATE CONTAINING CHIMERIC OLIGONUCLEOTIDES

      Nucleosides & nucleotides
    19. AGRAWAL S; TEMSAMANI J; GALBRAITH W; TANG JY
      PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES

      Clinical pharmacokinetics
    20. TEMSAMANI J; KUBERT M; AGRAWAL S
      SEQUENCING OF SYNTHETIC OLIGONUCLEOTIDES AND ANALOGS BY HOMOPOLYMERICTAILING

      Nucleic acids research
    21. TEMSAMANI J; KUBERT M; AGRAWAL S
      SEQUENCE IDENTITY OF THE N-1 PRODUCT OF A SYNTHETIC OLIGONUCLEOTIDE

      Nucleic acids research
    22. ZHANG RW; YAN JM; SHAHINIAN H; AMIN G; LU ZH; LIU TP; SAAG MS; JIANG ZW; TEMSAMANI J; MARTIN RR; SCHECHTER PJ; AGRAWAL S; DIASIO RB
      PHARMACOKINETICS OF AN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) IN HIV-INFECTED SUBJECTS

      Clinical pharmacology and therapeutics
    23. TEMSAMANI J; METELEV V; LEVINA A; AGRAWAL S; ZAMECNIK P
      INHIBITION OF IN-VITRO TRANSCRIPTION BY OLIGODEOXYNUCLEOTIDES

      Antisense research and development
    24. TEMSAMANI J; KUBERT M; TANG JY; PADMAPRIYA A; AGRAWAL S
      CELLULAR UPTAKE OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES AND THEIR ANALOGS

      Antisense research and development
    25. HABUS I; TEMSAMANI J; AGRAWAL S
      SYNTHESIS OF DIMERIC, TRIMERIC, AND TETRAMERIC BUILDING-BLOCKS WITH NOVEL CARBAMATE INTERNUCLEOSIDE LINKAGES AND THEIR INCORPORATION INTO OLIGONUCLEOTIDES

      Bioorganic & medicinal chemistry letters
    26. TEMSAMANI J; TANG JY; PADMAPRIYA A; KUBERT M; AGRAWAL S
      3 END MODIFIED OLIGODEOXYNUCLEOTIDES PHOSPHOROTHIOATE - PHARMACOKINETICS AND STABILITY IN MICE

      Journal of cellular biochemistry
    27. TANG JY; TEMSAMANI J; AGRAWAL S
      SELF-STABILIZED ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES - PROPERTIES AND ANTI-HIV ACTIVITY

      Nucleic acids research
    28. TEMSAMANI J; KUBERT M; AGRAWAL S
      A RAPID METHOD FOR QUANTITATION OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN BIOLOGICAL-FLUIDS AND TISSUES

      Analytical biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 03:48:10